Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies
SHANGHAI, Aug. 2, 2022 /PRNewswire/ -- In July 2022, Ablaze Pharma and Wenjiang District Government of Chengdu jointly signed the strategic agreement during the Conference of Major Advanced Manufacturing Projects by Foreign Direct Investment. About 26,000㎡ of industrial land is selected in the Chengdu Medical City, with an initial investment of 100 million USD to build-up an innovative R&D and manufacturing...
Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production
GMP commercial manufacturing license authorized by the National Drug Regulatory Authority, demonstrating Chime Biologics' capabilities in large scale commercial production Only 18 months to help LEPU Biopharma to obtain the approval of Puyouheng ™ in a new drug application demonstrating "Chime Biologics Unprecedented Speed" WUHAN, China, Aug. 2, 2022 /PRNewswire/ -- On August 2, 2022 (Beijing time),...
iHerb Achieves Customer Service Milestones
Users Highly Rate iHerb on Top Online Platforms PASADENA, Calif., Aug. 2, 2022 /PRNewswire/ -- iHerb, the world's largest e-commerce platform dedicated to health and wellness, reached significant milestones last month. The company is excited to announce its ratings among Google Customers, Google Play Store, and the Apple App Store. With a...
Sironax Announces Closing of $200 Million Series B Financing
Financing from new and existing investors will support pipeline progression and expansion for age-related degenerative diseases BEIJING, Aug. 2, 2022 /PRNewswire/ -- Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases, today announced the completion of a $200 million Series B financing. The round was led by Gaorong...
China Life Insurance Company Limited – Change of President
BEIJING, Aug. 2, 2022 /PRNewswire/ -- China Life Insurance Company Limited (the "Company") (NYSE: LFC; SSE: 601628; HKSE: 2628) announced today that due to the adjustment of work arrangements, Mr. Su Hengxuan tendered his resignation as the President, an Executive Director and a member of the Strategy and Assets and Liabilities Management Committee of the Company on August 1,...
Dr Ivan Puah Recommends Fat Grafting As A Solution Following Post-surgery Scars or Disfigurement
Fat grafting is highly recommended as part of the corrective surgery method to correct facial or body disfigurement from liposuction, laparoscopy or surgeries that cause dents and irregular contours. SINGAPORE, Aug. 2, 2022 /PRNewswire/ -- Dr Ivan Puah, Medical Director at Amaris B. Clinic, who has over 15 years of practice in liposuction, gynecomastia surgery and two proprietary...
NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
ADELAIDE, Australia, Aug. 2, 2022 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce NEXTSTELLIS® (drospirenone and estetrol tablets) has been nominated for the 2022 Prix Galien USA Award for Best Pharmaceutical Agent. NEXTSTELLIS® is the first and only contraceptive pill containing a new low impact estrogen, estetrol (E4), and...
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
Implemented by the Centers for Disease Control and Prevention, the diagnosis code will accurately identify US patients with APDS, supporting care and research efforts LEIDEN, Netherlands, Aug. 2, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that a new diagnosis code for reporting cases...
Advanced Instruments Acquires SAL Scientific, Expertise, and a Range of Cell Growth Supplements in Support of Research & Drug Discovery Workflows
NORWOOD, Mass., Aug. 2, 2022 /PRNewswire/ -- Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the acquisition of SAL Scientific Ltd., a private company that develops and manufactures a portfolio of cell growth supplements for Chinese Hamster Ovary (CHO) and Human Embryonic Kidney (HEK) cells. These...
GenKOre develops hypercompact adenine base editors (ABEs)
DAEJEON, South Korea, Aug. 2, 2022 /PRNewswire/ -- GenKOre, a biotech start-up in Korea, succeeded in the development of ABEs based on its own hypercompact gene-editing technology and had the relevant study published on Nature Chemical Biology on August 2, 2022. Gene editing GenKOre (homepage: www.genkore.com) is a business spun off from the Korea Research Institute of...
